ribociclib
novartis
['breast', 'natalee', 'ribociclib', 'bcsm']
ribociclib + endocrine therapy led to a clinically meaningful improvement in idfs among patients w/ hr+/her2 early breast cancer compared w/ endocrine therapy alone, meeting the primary end point of the phase 3 natalee trial. #asco23 #bcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.